Transmission Dynamics of Carbapenemase-Encoding Genes in CREC from Guangdong Teaching Hospitals

Study Background and Research Question

Carbapenem-resistant Enterobacter cloacae (CREC) has emerged as a critical threat to public health, particularly in healthcare settings where multidrug-resistant organisms complicate infection management and treatment outcomes. The COVID-19 pandemic further exacerbated these challenges by increasing antibiotic usage and disrupting routine healthcare practices, potentially accelerating the spread of resistance determinants. While the global rise of carbapenem-resistant Enterobacteriaceae is well documented, there remains a gap in our understanding of the distribution, transmission mechanisms, and clinical impact of carbapenemase-encoding genes (CEGs) in CREC, especially in East Asian hospital settings during and after pandemic-related disruptions. The central research question addressed by Chen et al. (2025) focuses on the molecular epidemiology, genetic context, and transmission dynamics of CEGs in CREC isolates from eight tertiary teaching hospitals in Guangdong Province, China, across the period from December 2022 to June 2024.

Key Innovation from the Reference Study

The principal innovation of the reference study lies in its comprehensive, multi-hospital survey of CEG prevalence, localization (plasmid versus chromosome), and horizontal transfer potential in CREC. A notable advance is the detailed genotype-phenotype mapping, including the co-localization of blaNDM-1 on both chromosomal and plasmid DNA within the same clinical isolates. The study also quantifies the efficiency of conjugative transfer for major CEGs such as blaNDM-1, blaIMP, and blaKPC-2, providing actionable insights into the mechanisms underpinning the rapid dissemination of carbapenem resistance. By coupling molecular genotyping (ERIC-PCR) with epidemiological profiling, the authors illuminate transmission clusters and risk demographics, offering an integrated view of genetic mobility and clinical prevalence that is rarely achieved in regional surveillance studies.

Methods and Experimental Design Insights

Chen et al. analyzed 54 CREC isolates collected from eight tertiary teaching hospitals across Guangdong. The study employed a combination of molecular and microbiological techniques:

• PCR and plasmid elimination (variable-temperature SDS method) to identify and localize CEGs (notably blaNDM-1, blaIMP, and blaKPC-2) on chromosomal and plasmid DNA.
• ERIC-PCR genotyping paired with NTSYS software to classify isolates into 17 genotypes and assess relatedness.
• Phenotypic resistance profiling using the broth microdilution method to determine antimicrobial susceptibility to agents such as imipenem, cefepime, gentamicin, ceftazidime/avibactam, ciprofloxacin, and levofloxacin.
• Plasmid conjugation experiments to directly measure horizontal transfer rates of CEGs.
• Mobile genetic element detection to map the diversity and prevalence of transposable elements (with ISEcp1 being the most prevalent).

The study’s design allowed for robust correlation between molecular findings (e.g., gene localization and transferability) and clinical-epidemiological data (e.g., patient demographics, hospital department, and sample type).

Core Findings and Why They Matter

• High Prevalence and Plasmid Localization: 85.19% of isolates harbored one or more carbapenemase-encoding genes, with blaNDM-1 being the predominant type. Critically, a substantial fraction carried blaNDM-1 on both plasmids and chromosomes (33.33%), while 46.30% had the gene exclusively on plasmids. This dual localization underscores the versatility and stability of resistance traits in CREC populations.
• Efficient Horizontal Gene Transfer: Conjugation experiments revealed a 95.65% success rate for CEG transfer, particularly for blaNDM-1 and blaIMP, highlighting the alarming potential for rapid intra- and interspecies dissemination of carbapenem resistance.
• Multidrug Resistance Phenotypes: CEG-positive CREC isolates demonstrated significantly higher resistance rates to multiple antibiotics compared to CEG-negative strains, consistent with the global trend of carbapenemase gene linkage to broad-spectrum resistance determinants.
• Genotypic Diversity and Transmission Clusters: ERIC-PCR delineated 17 genotypes, with types E and G most prevalent and widely distributed across five hospitals. The presence of identical genotypes in geographically and clinically distinct settings suggests active clonal expansion and/or inter-hospital transmission.
• Epidemiological Risk Factors: The highest detection frequencies were observed in male patients, elderly populations, respiratory medicine departments, and sputum samples, offering guidance for targeted surveillance and intervention strategies.

Together, these findings provide compelling evidence that plasmid-mediated blaNDM-1 is central to CREC epidemiology in this region, with both vertical (clonal expansion) and horizontal (plasmid conjugation) transmission routes contributing to the resistance landscape. This has direct implications for infection control and molecular surveillance protocols (Chen et al., 2025).

Comparison with Existing Internal Articles

Several recent internal articles contextualize and expand on the molecular mechanisms and experimental workflows highlighted by Chen et al.:

• The article "Transmission and Genetics of Carbapenem Resistance in CREC During COVID-19" provides a systematic overview of CEG prevalence and clinical impact in Guangdong, echoing the reference study's emphasis on blaNDM-1's pivotal role and the necessity for molecular surveillance.
• "Plasmid Transmission of Carbapenemase Genes in CREC, 2022–2024" closely parallels the findings of Chen et al., highlighting efficient horizontal gene transfer and multidrug resistance phenotypes. Both works reinforce the importance of monitoring plasmid mobility and integrating molecular data with epidemiological trends.
• On the experimental front, "Chloramphenicol in Plasmid-Mediated Resistance: Mechanisms & Assay Design" explores the utility of chloramphenicol as a stringent selection agent in plasmid-based gene transfer studies, directly supporting workflows employed in CEG monitoring and horizontal transfer assays.

Together, these resources underscore the convergence of molecular epidemiology and experimental design in addressing the ongoing crisis of antimicrobial resistance.

Limitations and Transferability

While the findings from Chen et al. offer a granular look at CEG dynamics within Guangdong hospitals, several limitations should be considered:

• The study’s geographic scope, while spanning eight institutions, reflects a single province and may not capture genetic or epidemiological variability at the national or international scale.
• Sampling bias may arise due to the focus on teaching hospitals, potentially overlooking community or rural settings where resistance determinants may differ.
• Although the study rigorously quantifies transfer efficiency for major CEGs, the functional impact of minor or novel resistance genes, as well as their interaction with other mobile elements, remains to be explored.
• Clinical outcome data are limited; thus, direct links between genotype and patient prognosis are not established.

Nevertheless, the workflow—combining molecular, phenotypic, and epidemiological tools—offers a transferable framework for similar surveillance studies in other high-burden regions.

Protocol Parameters

• Plasmid selection assays: Use chloramphenicol at 25 μg/ml for stringent plasmids and 170 μg/ml for relaxed plasmids to ensure selective pressure and minimize background growth, as recommended in standard chloramphenicol protocols.
• Plasmid elimination (SDS method): Employ variable temperature (e.g., 42°C) to facilitate plasmid curing before CEG localization PCR; optimize exposure time based on plasmid stability.
• Conjugation experiments: Mix donor and recipient strains at a 1:1 ratio; incubate on non-selective media for 18–24 hours before plating on selective media containing appropriate antibiotics.
• ERIC-PCR typing: Use established primer sets and NTSYS software for cluster analysis; compare genotypes from different clinical departments to identify clonal spread.
• Antimicrobial susceptibility testing: Broth microdilution remains the gold standard for multidrug resistance phenotyping, with interpretation following CLSI/EUCAST guidelines.

Research Support Resources

For researchers replicating or extending these workflows, high-purity reagents are essential for reliable plasmid selection and resistance gene mobility studies. Chloramphenicol (2,2-dichloro-N-[(1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl]acetamide, SKU A2512) from APExBIO is widely utilized as a bacterial protein synthesis inhibitor and stringent selection agent in molecular biology research, supporting both routine and advanced plasmid selection assays. For optimal results, follow storage and concentration guidelines as detailed in the product dossier. These resources help ensure experimental reproducibility in the study of plasmid-mediated antimicrobial resistance.